Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases-Reference-Cited by-同舟云学术

Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

Published:2018-03-09 Issue:1 Volume:15 Page:
ISSN:1542-6416
Container-title:Clinical Proteomics
language:en
Short-container-title:Clin Proteom

Author:

Zila Nina,Bileck Andrea,Muqaku Besnik,Janker Lukas,Eichhoff Ossia M.,Cheng Phil F.,Dummer Reinhard,Levesque Mitchell P.,Gerner Christopher,Paulitschke Verena

Funder

Promedica Stiftung

MUW mobility

URPP Translational Cancer Research

Louis Widmer

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Clinical Biochemistry,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12014-018-9189-x.pdf

Reference96 articles.

1. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82:364–80.

2. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007;82:490–513.

3. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004;22:2865–72.

4. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002;94:2698–705.

5. Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu W-J, et al. Prognostic factors for survival in melanoma patients with brain metastases. Cancer US. 2011;117:1687–96.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Profiling of Advanced Melanoma Patients to Predict Therapeutic Response to Anti-PD-1 Therapy;Clinical Cancer Research;2023-10-20

2. Proteomic profiling of cutaneous melanoma explains the aggressiveness of distant organ metastasis;Experimental Dermatology;2023-04-21

3. ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma;Cancer Research;2023-03-22

4. Myofibroblast stroma differentiation in infiltrative basal cell carcinoma is accompanied by regulatory T‐cells;Journal of Cutaneous Pathology;2023-01-16

5. Genomic and proteomic findings in early melanoma and opportunities for early diagnosis;Experimental Dermatology;2022-11-28